European Archives - Page 819 of 991 - European Medical Journal

Clinical Management of Drug-Induced Dyskinesia in Parkinson’s Disease: Why Current Approaches May Need to Be Changed to Optimise Quality of Life

Parkinson’s disease is a complex, progressive neurodegenerative disorder associated with both motor and non-motor symptoms. Current treatment strategies…

Occupational Allergies: A Brief Review

Occupational allergies are groups of work-related disorders that are accompanied by immunologic reaction to workplace allergens and include occupational…

Allergen-Specific Immunotherapy

Allergen-specific immunotherapy remains the only causal treatment of allergic disease to date. Its efficacy in symptom reduction was demonstrated in…

Management of Cardiovascular Risk Factors in Type 2 Diabetes Mellitus Patients

People with Type 2 diabetes mellitus (T2DM), compared with non-diabetic individuals, have increased cardiovascular risk. Part of this excess risk is…

Gene Delivery from Stents for Prevention of In-Stent Restenosis

The increasing sophistication of vascular stent design, especially devices that combine mechanical support with local drug delivery to the vascular wall…

Revolution of Drug-Eluting Coronary Stents: An Analysis of Market Leaders

Percutaneous coronary intervention with drug-eluting stents (DES) is a well-established and widely-accepted treatment approach in patients with coronary…

EMJ

First Project for the Winton Centre: Redesigning PREDICT

At the start of November 2016 the Winton Centre for Risk and Evidence Communication was opened within the Department of Pure Mathematics and Mathematical…

Sepsis-Induced Immune Paralysis Reversed by β-Glucan

SEPSIS is a life-threatening condition with inefficient treatment options available at present. With an incidence of approximately 2–30 per 10,000 people…

Association Found Between Vitamin D Levels and Breast Cancer Prognosis

VITAMIN D serum biomarker levels, particularly 25-hydroxyvitamin D, can be used to gauge vitamin deficiency or abundance among patients. In 2003 alone…

Enzyme Deficiency Provides New Treatment Target for Prader-Willi Syndrome

DEFICIENCY of the prohormone covertase (PC1) enzyme in the brain has been linked to the neuro-hormonal abnormalities found in patients with Prader-Willi…